Sunday, December 21, 2014 Last update: Yesterday, 8:33 AM - Covering Large & Obscure Tech Companies Since 1996

Cerus to Present at the Baird 2014 Health Care Conference on September 3, 2014

Companies mentioned in this article: Cerus Corporation

CONCORD, Calif. -- (BUSINESS WIRE) -- Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, vice president and chief financial officer, is scheduled to present a corporate update at the Baird 2014 Health Care Conference at 7:55 AM ET on Wednesday, September 3, 2014.

A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at A replay will be available for approximately two weeks following the completion of the event.


Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See for more information.

INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Copyright © Business Wire 2014

Cerus Corporation
Lainie Corten, 925-288-6319
Senior Director, Global Marketing & Investor Relations